Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells Is a Primary Target for Therapy with Tyrosine Kinase Inhibitors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (48)
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 • 11,185 citations
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 • 9,201 citations
Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery
1997 • 5,665 citations
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 • 5,383 citations
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
2003 • 4,433 citations
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
2004 • 4,293 citations
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 • 2,522 citations
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 • 1,834 citations
Clinical translation of angiogenesis inhibitors
2002 • 1,518 citations
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
2005 • 1,081 citations
EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment
2005 • 792 citations
Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib
2005 • 782 citations
Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
2000 • 750 citations
Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer
2005 • 724 citations
Conditional Suppression of Cellular Genes: Lentivirus Vector-Mediated Drug-Inducible RNA Interference
2003 • 700 citations
Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.
2000 • 505 citations
The seed and soil hypothesis: vascularisation and brain metastases
2002 • 423 citations
The organ microenvironment and cancer metastasis
2002 • 414 citations
Signal transduction and oncogenesis by ErbB/HER receptors
2004 • 382 citations
Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
2000 • 376 citations
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
2007 • 370 citations
IncreasedHER2Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients
2005 • 365 citations
In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice.
1988 • 356 citations
AEE788
2004 • 315 citations
Growth factor binding to the pericellular matrix and its importance in tissue engineering☆
2007 • 276 citations
The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival
1993 • 224 citations
Src activation regulates anoikis in human colon tumor cell lines
2002 • 210 citations
Blockade of Epidermal Growth Factor Receptor Signaling on Tumor Cells and Tumor-Associated Endothelial Cells for Therapy of Human Carcinomas
2002 • 151 citations
Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.
2003 • 149 citations
Dual Inhibition of Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor Phosphorylation by AEE788 Reduces Growth and Metastasis of Human Colon Carcinoma in an Orthotopic Nude Mouse Model
2005 • 137 citations
Overview of angiogenesis: Biologic implications for antiangiogenic therapy
2001 • 121 citations
Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer
2006 • 117 citations
Clinical relevance of transforming growth factor α, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors
1998 • 116 citations
Epidermal Growth Factor Modulates the Expression of Vascular Endothelial Growth Factor in the Human Prostate
2001 • 111 citations
Simultaneous Blockade of Platelet-Derived Growth Factor-Receptor and Epidermal Growth Factor-Receptor Signaling and Systemic Administration of Paclitaxel as Therapy for Human Prostate Cancer Metastasis in Bone of Nude Mice
2004 • 105 citations
Targeting the Expression of Platelet-Derived Growth Factor Receptor by Reactive Stroma Inhibits Growth and Metastasis of Human Colon Carcinoma
2006 • 102 citations
Targeting Platelet-Derived Growth Factor Receptor on Endothelial Cells of Multidrug-Resistant Prostate Cancer
2006 • 93 citations
Tumor Cell and Endothelial Cell Therapy of Oral Cancer by Dual Tyrosine Kinase Receptor Blockade
2004 • 87 citations
Antivascular Therapy for Orthotopic Human Ovarian Carcinoma through Blockade of the Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptors
2005 • 75 citations
Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels
2006 • 62 citations
Activation of the Platelet-Derived Growth Factor-Receptor Enhances Survival of Murine Bone Endothelial Cells
2004 • 56 citations
Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens
2007 • 55 citations
Understanding the New Genetics of Responsiveness to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
2007 • 49 citations
A Novel Mechanism of Resistance to Epidermal Growth Factor Receptor Antagonism In vivo
2007 • 46 citations
Epidermal Growth Factor Receptor—Negative Colorectal Cancer: Is There Truly Such an Entity?
2005 • 40 citations
Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice
2005 • 38 citations
Induction of Apoptosis in Tumor-Associated Endothelial Cells and Therapy of Orthotopic Human Pancreatic Carcinoma in Nude Mice
2005 • 33 citations
Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells in Human Renal Cell Carcinoma Is a Primary Target for Therapy by Tyrosine Kinase Inhibitors
2006 • 24 citations
Cited By (0)
No citing papers found in database